drugset / Trial / NCT02924454

Effects of Lipid Emulsion on the Pharmacokinetic and Pharmacodynamic Properties of Metoprolol.

NCT02924454

Phase 4 Completed 10 enrolled Mikkel Bring Christensen
RandomizedCrossoverDouble-blindBasic science

Summary

The aim of this study is to investigate whether intravenous lipid emulsion is effective in attenuating the clinical effects of a cardioactive drug, exemplified by the beta-blocking agent metoprolol. In addition, the investigators will clarify how intravenous lipid emulsion affects the pharmacokinetic parameters of metoprolol.

Timeline

Start
2016-09
Primary completion
2017-03-10
Completion
2017-03-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Intralipid Other / unclassified 0.25 unknown Intravenous
Subject Metoprolol Other / unclassified 0.5 mg/ml Intravenous

Indications